Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol

Drug Development and Industrial Pharmacy

Volumn 38, Issue 3, 2012, Pages 314-322

  Lu, Xin Yi ^a   Hu, Song ^a   Jin, Yi ^a   Qiu, Li Yan ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Anti tumor effect; Cytotoxicity; Liposome; Resveratrol; Reverse phase evaporation method

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHOLESTEROL; LIPOSOME; MACROGOL; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; RESVERATROL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL LINE; CELL STRAIN HEPG2; CYTOTOXICITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; FEMALE; HELA CELL; HUMAN; HUMAN CELL; LIPOSOME ENCAPSULATION; PARTICLE SIZE; SOYBEAN;

ANTICARCINOGENIC AGENTS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LIPOSOMES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SOLUBILITY; STILBENES; SURFACE PROPERTIES; TUMOR CELLS, CULTURED;

EID: 84856408774     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.602410     Document Type: Article

References (46)

1. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM. (2002). Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med, 9:77-79.
2. Demrow HS, Slane PR, Folts JD. (1995). Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation, 91:1182-1188.
3. Fitzpatrick DF, Hirschfield SL, Coffey RG. (1993). Endotheliumdependent vasorelaxing activity of wine and other grape products. Am J Physiol, 265:H774-H778. (Pubitemid 23273620)
4. Lekakis J, Rallidis LS, Andreadou I, Vamvakou G, Kazantzoglou G, Magiatis P et al. (2005). Polyphenolic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil, 12:596-600. (Pubitemid 44972990)
5. Wang Z, Zou J, Cao K, Hsieh TC, Huang Y, Wu JM. (2005). Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels. Int J Mol Med, 16:533-540.
6. Fuhrman B, Lavy A, Aviram M. (1995). Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr, 61:549-554.
7. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. (1993). Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet, 341:454-457. (Pubitemid 23054518)
8. Zern TL, West KL, Fernandez ML. (2003). Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J Nutr, 133:2268-2272. (Pubitemid 36841552)
9. Khanduja KL, Bhardwaj A, Kaushik G. (2004). Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. J Nutr Sci Vitaminol, 50:61-65. (Pubitemid 38405211)
10. Aziz MH, Afaq F, Ahmad N. (2005). Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochem Photobiol, 81:25-31. (Pubitemid 40327556)
11. Afaq F, Adhami VM, Ahmad N. (2003). Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol Appl Pharmacol, 186:28-37. (Pubitemid 36262946)
12. Feng YH, Zhou WL, Wu QL, Li XY, Zhao WM, Zou JP. (2002). Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol Sin, 23:893-897.
13. Gao X, Deeb D, Media J, Divine G, Jiang H, Chapman RA et al. (2003). Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem Pharmacol, 66:2427-2435. (Pubitemid 37456749)
14. Gupta YK, Briyal S, Chaudhary G. (2002). Protective effect of transresveratrol against kainic acid-induced seizures and oxidative stress in rats. Pharmacol Biochem Behav, 71:245-249.
15. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG et al. (2003). Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425:191-196. (Pubitemid 37150899)
16. Baur JA, Sinclair DA. (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov, 5:493-506.
17. Khanduja KL, Bhardwaj A, Kaushik G. (2004). Resveratrol inhibits N-nitrosodiethylamine-induced ornithine decarboxylase and cyclooxygenase in mice. J Nutr Sci Vitaminol (Tokyo), 50:61-65. (Pubitemid 38405211)
18. Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, Ding Y et al. (2002). Suppression of N-nitrosomethylbenzylamine (NMBA)- induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis, 23:1531-1536. (Pubitemid 35012434)
19. Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. (2009). Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms. Arch Biochem Biophys, 486:95-102.
20. Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, Lee YS et al. (2009). Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res, 59:330-337.
21. Li J, Qin Z, Liang Z. (2009). The prosurvival role of autophagy in resveratrol-induced cytotoxicity in human U251 glioma cells. bmc Cancer, 9:215.
22. Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov, 4:145-160. (Pubitemid 40282557)
23. Wang M, Thanou M. (2010). Targeting nanoparticles to cancer. Pharmacol Res, 62:90-99.
24. Skubitz KM. (2003). Phase II trial of pegylated-liposomal doxorubicin (Doxil) in sarcoma. Cancer Invest, 21:167-176. (Pubitemid 36532162)
25. Moghimi SM, Szebeni J. (2003). Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res, 42:463-478. (Pubitemid 37237636)
26. Mohammed AR, Bramwell VW, Coombes AG, Perrie Y. (2006). Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products. Methods, 40:30-38. (Pubitemid 44415496)
27. Juan ME, Lamuela-Raventós RM, de la Torre-Boronat MC, Planas JM. (1999). Determination of trans-resveratrol in plasma by HPLC. Anal Chem, 71:747-750.
28. Fritze A, Hens F, Kimpfler A, Schubert R, Peschka-Süss R. (2006). Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim Biophys Acta, 1758:1633-1640. (Pubitemid 44466698)
29. Kang OH, Lee GH, Choi HJ, Park PS, Chae HS, Jeong SI et al. (2007). Ethyl acetate extract from Angelica Dahuricae Radix inhibits lipopolysaccharide- induced production of nitric oxide, prostaglandin E2 and tumor necrosis factor-alphavia mitogen-activated protein kinases and nuclear factor-kappaB in macrophages. Pharmacol Res, 55:263-270. (Pubitemid 46522544)
30. Li L, ten Hagen TL, Schipper D, Wijnberg TM, van Rhoon GC, Eggermont AM et al. (2010). Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia. J Control Release, 143:274-279.
31. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. (1991). Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta, 1066:29-36.
32. Liu W, Liu WL, Liu CM, Liu JH, Yang SB, Zheng HJ et al. (2011). Medium-chain fatty acid nanoliposomes for easy energy supply. Nutrition, 27:700-706.
33. Harland CW, Bradley MJ, Parthasarathy R. (2010). Phospholipid bilayers are viscoelastic. Proc Natl Acad Sci usa, 107:19146-19150.
34. Sriwongsitanont S, Ueno M. (2004). Effect of freeze-thawing and polyethylene glycol (PEG) lipid on fusion and fission of phospholipid vesicles. Chem Pharm Bull, 52:641-642. (Pubitemid 41701923)
35. Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Simonoska M, Calis S, Trajkovic-Jolevska S et al. (2005). The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm, 291:79-86. (Pubitemid 40221999)
36. Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. (1991). Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta, 1062:77-82.
37. Chonn A, Cullis PR, Devine DV. (1991). The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. J Immunol, 146:4234-4241.
38. Dos Santos N, Allen C, Doppen AM, Anantha M, Cox KA, Gallagher RC et al. (2007). Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochim Biophys Acta, 1768:1367-1377. (Pubitemid 46782695)
39. Mayhew EG, Lasic D, Babbar S, Martin FJ. (1992). Pharmacokinetics and antitumor activity of epirubicin encapsulated in longcirculating liposomes incorporating a polyethylene glycolderivatized phospholipid. Int J Cancer, 51:302-309.
40. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. (1999). Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol, 237:97-132. (Pubitemid 28554861)
41. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP et al. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res, 55:3752-3756.
42. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release, 65:271-284. (Pubitemid 30122932)
43. Charrois GJ, Allen TM. (2003). Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim Biophys Acta, 1609:102-108. (Pubitemid 36044071)
44. Seynhaeve AL, Hoving S, Schipper D, Vermeulen CE, de Wiel- Ambagtsheer G, van Tiel ST et al. (2007). Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. Cancer Res, 67:9455-9462. (Pubitemid 47535935)
45. Narayanan NK, Nargi D, Randolph C, Narayanan BA. (2009). Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer, 125:1-8.
46. Kristl J, Teskac K, Caddeo C, Abramovic Z, Sentjurc M. (2009). Improvements of cellular stress response on resveratrol in liposomes. Eur J Pharm Biopharm, 73:253-259.